This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.
One of the primary causes of night sweats, especially in women, is menopause or the transition period of perimenopause. | ...
hormone replacement therapy was found to lessen hot flash severity, but further study linked it to a heightened odds for breast cancer and stroke, and many women now avoid the treatment.
Hot flashes are one of the most common and undoubtedly the most uncomfortable symptoms associated with menopause. If you’re menopausal you will know all about the sudden sensations of intense ...
Primary ovarian insufficiency (POI) affects nearly one percent of women under 40. Here, Sheree Hargreaves receives a ...
Timely identification and treatment of bothersome hot flashes have the potential to improve the lives of many women and save ...
Hot flashes and night sweats are well-known problems of menopause, but now dentists are saying women may also face problems with their teeth. The drop in estrogen levels brought on by menopause ...
Struggling with hot flashes, mood swings or weight gain during perimenopause? Simple perimenopause “micro habits” added to your daily routine can help balance fluctuating hormones like estrogen and ...
US FDA accepts Bayer’s NDA for elinzanetant to treat moderate-to-severe VMS associated with menopause: Berlin Friday, October 11, 2024, 11:00 Hrs [IST] Bayer announced that the ...
IT CAN BE A CHALLENGE FOR MANY WOMEN IN THEIR 40S AND 50S, BUT THERE ARE TREATMENT OPTIONS ... YEAH, ABSOLUTELY. Menopausal hot flashes are linked to cold experienced during childhood and ...
The FDA issued a warning regarding the potential risk of a rare but serious liver injury associated with the drug Veozah, a medication approved in May 2023 to treat moderate to severe hot flashes.
Hot flashes are one of the most commonly reported symptoms of menopause and the most common ... [+] menopause symptom for which women seek treatment ... menopause is a natural transition and ...